Allogene Therapeutics, Inc. (ALLO) CEO David Chang on Q2 2021 Results – Earnings Call Transcript
Allogene Therapeutics, Inc. (ALLO) Q2 2021 Earnings Conference Call August 4, 2021 5:00 PM ET
Company Participants
Christine Cassiano – Chief Communications Officer
David Chang – President and CEO
Rafael Amado – EVP, Research and Development and CMO
Eric…
